Published: Jan. 8, 2021

The immediate family/household members of CU Boulder faculty, staff and students with a Buff OneCard are eligible for free surveillance monitoring testing at CU Boulder. The program for these affiliates has been extended from the previously scheduled cutoff date of Jan. 8 and will continue as long as testing capacity permits.

All participants must be asymptomatic and arrive at the testing site accompanied by their CU Boulder affiliate/Buff OneCard holder. Buff OneCard holders seeking testing must first complete theirĚý. Surveillance monitoring tests are free to CU Boulder Buff OneCard holders’ immediate family/household members. For individuals with difficulty providing a sample in a tube, such as young children, as long as the participant is able to provide the necessary amount of saliva, the test can be processed.

There are four sites available, Monday to Friday. Hours of operation are 10 a.m. to 4 p.m. at all sites:

Testing notifications

The surveillance monitoring test laboratory looks for signs of SARS-CoV-2 (the virus that causes COVID-19). Notifications of results are provided as follows:

  • If a Buff OneCard holder’s own sample indicates signs of the virus, the Buff OneCard holder will receive an email by the end of the next day from either Medical Services (for students) or Human Resources (for faculty/staff).
  • If a Buff OneCard holder’s test result shows no signs of the virus, is inconclusive or is unable to be processed, a notification email is sent by the end of the next day fromĚýCOVID-19-monitoring@colorado.edu.
  • If a family or household member’s test result indicates signs of the virus, the associated Buff OneCard holder will receive an email by the end of the next day from the COVID-19 monitoring email address for every person whose test result indicates signs of the virus.
  • If a family or household member’s test result indicates no signs of the virus, is inconclusive, or is unable to be processed, no notification is sent.

91ÖĆƬł§ surveillance monitoring

The surveillance monitoring program involves a saliva-based polymerase chain reaction, or PCR, test that looks for signs of SARS-CoV-2 among asymptomatic individuals. The test is not diagnostic and cannot medically determine if a person is positive or negative for COVID-19.